Fig. 2: CD82 overexpression in retina and ON was achieved by Intravitreal injection of recombinant adeno-associated virus rAAV2/9-Cd82-mCherry. | Cell Death & Disease

Fig. 2: CD82 overexpression in retina and ON was achieved by Intravitreal injection of recombinant adeno-associated virus rAAV2/9-Cd82-mCherry.

From: CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice

Fig. 2

a Immunostaining of CD82 shown in whole globe, retina, ON, and ONH in CTR, AAV-Vehicle, AAV-Cd82 groups 28 days after virus injection, n = 5 eyes. Scale bars, 200 μm for Global; 50 μm for Retina, ON, and ONH. b Western blot showing protein levels of CD82 in mouse retina, ON and ONH tissues from CTR, AAV-Vehicle, AAV-Cd82 groups 28 days after virus injection. c Statistical analysis of the data shown in (b). The data were expressed as mean ± S.E.M., n = 5, one-way ANOVA ***P < 0.001.

Back to article page